Human CD30/TNFRSF8 Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | AF229SP-Each-of-1 | In Stock | ₹ 17,844.50 |
AF229SP - Each of 1
In Stock
Quantity
1
Base Price: ₹ 17,844.50
GST (18%): ₹ 3,212.01
Total Price: ₹ 21,056.51
Antigen
CD30/TNFRSF8
Classification
Polyclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Host Species
Goat
Purification Method
Affinity Purified
Regulatory Status
RUO
Primary or Secondary
Primary
Test Specificity
Detects human CD30 in direct ELISAs and Western blots.
Target Species
Human
Isotype
IgG
Applications
Western Blot, Immunocytochemistry
Concentration
LYOPH
Dilution
Western Blot 0.1 ug/mL, Agonist Activity, Immunocytochemistry 5-15 ug/mL
Gene Accession No.
P28908
Gene Symbols
TNFRSF8
Immunogen
S. frugiperdainsect ovarian cell lineSf21-derived recombinant human CD30 Phe19-Lys379 Accession # P28908
Quantity
25 μg
Research Discipline
Agonist Activity
Gene ID (Entrez)
943
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Related Products
Description
- CD30/TNFRSF8 Polyclonal specifically detects CD30/TNFRSF8 in Human samples
- It is validated for Western Blot, Agonist Activity, Immunocytochemistry.